XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.10

+0.4%

Dec 4 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9599)	4/12/1999 11:35:00 AM
From: Bluegreen	Read Replies (3) of 17367

George, once again you let us down on the reporting.<g> PLEASE READ BELOW>>>>>>>>Including the events mentioned above, Genentech recently announced the following: -- Decided to continue development of the anti-CD11a (hu1124) monoclonal antibody product for psoriasis in collaboration with Xoma, Ltd., through Phase III clinical trials. Also, agreed with XOMA Ltd. to license its technology for pharmaceutical antibody production designed to reduce production costs and increase yields.<<<<<<<<<<<<<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next